PharmaCielo Ltd logo

PharmaCielo Ltd

1
TSXV:PCLO (Canada)   Ordinary Shares
C$ 0.09 (+5.88%) Dec 24
At Loss
Market Cap:
C$ 14.43M ($ 10.64M)
Enterprise V:
C$ 35.30M ($ 25.18M)
Volume:
37.00K
Avg Vol (2M):
208.81K
Trade In:
Volume:
37.00K
At Loss
Avg Vol (2M):
208.81K

Business Description

PharmaCielo Ltd logo
PharmaCielo Ltd
NAICS : 325411 SIC : 3741
ISIN : CA00035L1022

Share Class Description:

TSXV:PCLO: Ordinary Shares
Description
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -0.39
Debt-to-Equity -2.75
Debt-to-EBITDA -2.25
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -17.17
Distress
Grey
Safe
Beneish M-Score -21.32
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 42.29
9-Day RSI 44.31
14-Day RSI 46.19
6-1 Month Momentum % -48.39
12-1 Month Momentum % -48.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.15
Quick Ratio 0.07
Days Inventory 305.35
Days Sales Outstanding 44.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.8
Shareholder Yield % -36.84

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 1.23
Operating Margin % -227.61
Net Margin % -540.32
FCF Margin % -118.79
ROA % -63.06
ROIC % -18.52
ROC (Joel Greenblatt) % -57.02
ROCE % -350.91

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 5.67
EV-to-EBIT -3.4
EV-to-EBITDA -3.88
EV-to-Revenue 13.92
EV-to-FCF -11.44
Earnings Yield (Greenblatt) % -29.41
FCF Yield % -20.19

Financials (Next Earnings Date:2025-03-02 Est.)

TSXV:PCLO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PharmaCielo Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 2.597
EPS (TTM) (C$) -0.09
Beta 1.05
Volatility % 91
14-Day RSI 46.19
14-Day ATR (C$) 0.013067
20-Day SMA (C$) 0.09825
12-1 Month Momentum % -48.39
52-Week Range (C$) 0.065 - 0.29
Shares Outstanding (Mil) 169.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PharmaCielo Ltd Filings

Filing Date Document Date Form
No Filing Data

PharmaCielo Ltd Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

PharmaCielo Ltd Frequently Asked Questions

What is PharmaCielo Ltd(TSXV:PCLO)'s stock price today?
The current price of TSXV:PCLO is C$0.09. The 52 week high of TSXV:PCLO is C$0.29 and 52 week low is C$0.07.
When is next earnings date of PharmaCielo Ltd(TSXV:PCLO)?
The next earnings date of PharmaCielo Ltd(TSXV:PCLO) is 2025-03-02 Est..
Does PharmaCielo Ltd(TSXV:PCLO) pay dividends? If so, how much?
PharmaCielo Ltd(TSXV:PCLO) does not pay dividend.

Press Release

Subject Date
No Press Release